Latest Steatohepatitis Stories
MarketResearch.com announces the addition of a new market research report in Pharmaceuticals to their product offering: OpportunityAnalyzer: Nonalcoholic Steatohepatitis (NASH) - Opportunity Analysis
RnRMarketResearch.com adds Latest Report on “OpportunityAnalyzer: Nonalcoholic Steatohepatitis (NASH) – Opportunity Analysis and Forecasts to 2017” to its store.
A groundbreaking study of nearly 2,300 extremely obese diabetes patients, led by the Translational Genomics Research Institute (TGen), has identified genes associated with unhealthy liver function.
A new, non-invasive imaging technique, magnetic resonance elastography (MRE), can now help physicians accurately detect fibrosis (scarring) in children with chronic liver disease – a growing problem due in part to increasing obesity rates.
Oregon State University researchers say omega-3 fatty acid DHA, such as found in Omega XL, has a powerful effect in preventing liver inflammation and fibrosis. Hollywood,
Scientists at the Arkansas Children's Nutrition Center, a U.S. Department of Agriculture Agricultural Research Service Human Nutrition Research Center at the University of Arkansas for Medical Sciences, led by Dr. Martin Ronis have determined that dietary substitution of saturated fats enriched in medium chain triglycerides (MCT) for polyunsaturated fat prevents the development of nonalcoholic fatty liver disease (NAFLD).
Vitamin E could be a new weapon in the fight against obesity-related liver disease known as nonalcoholic steatohepatitis, according to new research.
New research reveals that advanced fibrosis is a significant predictor of mortality in patients with nonalcoholic fatty liver disease (NAFLD), largely brought about by cardiovascular causes.
- The act of sweetening by admixture of some saccharine substance.